Shanghai Yizhong core product paclitaxel micelle for injection has been approved to be put on the market.
Shanghai Yizhong announced that the company learned from the information release on the website of the State Drug Administration on October 28 that the company's core product paclitaxel polymer micelles for injection (referred to as "paclitaxel micelles") had been approved for listing. Paclitaxel is the cornerstone of chemotherapy in the treatment of tumor diseases, with a wide range of indications and rich clinical use. As an innovative dosage form of paclitaxel, paclitaxel micelle belongs to the national major new drug creation project.
Liaoning Chengda won the card of Jilin Aodong.
Liaoning Chengda announced that Jilin Aodong, a shareholder of the company, increased its holdings of 966100 shares of the company through a centralized trading system on October 28, 2021, accounting for 0.06% of the number of shares issued by the company. Jilin Aodong and its concerted actor Yanbian Pharmaceutical Co., Ltd. hold a total of 5% of the company. Jilin Aodong and the concerted action plan to continue to increase the company's holdings of no less than 1 million shares within 12 months.
Sanfang Xiang plans to raise no more than 4.5 billion yuan of controlling shareholders to participate in the subscription.
Sanfang Lane announced that the company intends to issue shares in a non-public offering, raising no more than 4.5 billion yuan for Jiangsu Hailun Petrochemical Co., Ltd. PTA technical transformation and expansion project, supplementary liquidity. This issue is aimed at no more than 35 specific investors, including the controlling shareholder Sanfangxiang Group, among which Sanfangxiang Group intends to subscribe for no less than 200 million yuan and no more than 800 million yuan.
Xiamen tungsten Xinneng plans to invest 620 million yuan in the equipment purchase and installation project of lithium battery cathode material production line.
Xiamen tungsten Xinneng announced that while raising and investing in the project, the company intends to invest 620.066 million yuan to start the construction of the third phase of the project and carry out the equipment procurement and installation project of the production line of 20, 000 tons of lithium-ion battery cathode materials in Haihai base. after the completion of the first, second and third phases of the industrialization project of 40000 tons of lithium-ion battery materials, the company's Haiyi base will reach an annual production capacity of 40000 tons of lithium battery cathode materials.
Guotou Electric Power: unit 4 of Lianghekou Hydropower Station on the Yalong River was put into operation.
According to the report of Yalong River Basin Hydropower Development Co., Ltd., the No. 4 unit of Lianghekou Hydropower Station on the Yalong River was officially put into operation on October 27. The total installed capacity of the power station is 3 million kilowatts, and the average annual generating capacity is about 11 billion kilowatt hours. The first batch of units of the power plant was put into operation on September 29th this year, and three units have been put into production totaling 1.5 million kilowatts.
Yiwei Lithium Energy signs Strategic Cooperation Framework Agreement for 50GWh Power Storage Battery Project
Yiwei LiNeng announced that the company and the Management Committee of Chengdu Economic and technological Development Zone signed the "Yiwei Lithium Energy 50GWh Power Storage Battery Project Strategic Cooperation Framework Agreement" on October 27th, 2021. The two sides intend to give full play to their respective advantages and carry out good cooperation in the field of lithium-ion battery production and research and development. The company has reached a relevant agreement on the construction of the "Yiwei Lithium 50GWh Power Storage Battery Project" on newly requisitioned land in the area under the jurisdiction of the Management Committee of Chengdu Economic and technological Development Zone.